1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions

Author: Dungan, Kathleen M

Source: Expert Review of Molecular Diagnostics, Volume 8, Number 1, January 2008 , pp. 9-19(11)

Publisher: Expert Reviews

Buy & download fulltext article:

OR

Price: $73.00 plus tax (Refund Policy)

Abstract:

1,5-anhydroglucitol (1,5-AG) is a validated marker of short-term glycemic control. It is a metabolically inert polyol that competes with glucose for reabsorption in the kidneys. Otherwise stable levels of 1,5-AG are rapidly depleted as blood glucose levels exceed the renal threshold for glucosuria. 1,5-AG more accurately predicts rapid changes in glycemia than hemoglobin A1C (A1C) or fructosamine. It is also more tightly associated with glucose fluctuations and postprandial glucose. Thus, 1,5-AG may offer complementary information to A1C. This review will summarize the limitations of current methods of assessing glycemic control, assess the data to support 1,5-AG as a glycemic marker and highlight the scenarios by which 1,5-AG may fill the gap in assessing glycemic control.

Keywords: 1,5-anhydroglucitol; A1C; glucose; glycemic control; glycemic excursion; glycemic variability; post-prandial glucose

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737159.8.1.9

Affiliations: 1: Ohio State University, 4th Floor McCampbell Hall, 1581 Dodd Drive, Columbus, OH 43210, USA., Email: kathleen.dungan@osumc.edu

Publication date: 2008-01-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page